白癜风患者黑色素瘤与非黑色素瘤皮肤癌风险:英国人群队列研究
基于英国Optimum Patient Care Research Database 2010-2020年电子初级保健记录,将15,156例白癜风患者按年龄、性别和全科诊所与60,615例无白癜风对照匹配,采用Cox回归比较皮肤癌发病率。白癜风与皮肤癌新发风险降低38%相关(aHR=0.62,95%CI=0.52-0.75,P<0.001),黑色素瘤、鳞状细胞癌和基底细胞癌风险均降低,光化性角化病无显著关联。
要点
- 白癜风患者新发皮肤癌风险降低38%(aHR=0.62,95%CI=0.52-0.75,P<0.001)。
- 黑色素瘤风险降低(aHR=0.39,95%CI=0.23-0.65,P<0.001)。
- 光化性角化病与白癜风无显著关联(aHR=0.88,95%CI=0.77-1.01)。
核心结论
- 白癜风患者黑色素瘤和非黑色素瘤皮肤癌发病率显著降低。
- 鉴于光疗等治疗可能增加皮肤癌风险的担忧,该发现为白癜风患者和管理该病的临床医生提供了 reassurance。
研究设计与样本
- 基于英国Optimum Patient Care Research Database 2010-2020年电子初级保健记录的基于人群的队列研究。
- 15,156例白癜风患者按年龄、性别和全科诊所与60,615例无白癜风对照匹配。
- 采用Cox回归比较白癜风患者与对照的黑色素瘤、非黑色素瘤皮肤癌(鳞状细胞癌和基底细胞癌)及光化性角化病发病率。
主要发现
- 白癜风与新发皮肤癌风险降低38%相关(aHR=0.62,95%CI=0.52-0.75,P<0.001)。
- 黑色素瘤风险降低(aHR=0.39,95%CI=0.23-0.65,P<0.001)。
- 鳞状细胞癌风险降低(aHR=0.67,95%CI=0.49-0.90,P<0.01)。
- 基底细胞癌风险降低(aHR=0.65,95%CI=0.51-0.83,P<0.001)。
- 光化性角化病无显著关联(aHR=0.88,95%CI=0.77-1.01)。
临床怎么用
- 原文未据此给出推荐。
- 作者指出,鉴于光疗等治疗可能增加皮肤癌风险的担忧,该发现为白癜风患者和管理该病的临床医生提供了 reassurance。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although genetic studies have found an inverse relationship between vitiligo and skin cancer, epidemiological evidence is conflicting. We investigated the risk of skin cancer in adults with vitiligo using United Kingdom electronic primary care records from the Optimum Patient Care Research Database 2010-2020. Vitiligo cases were age, sex, and general practitioner practice matched to population controls without vitiligo. Incidence of melanoma, nonmelanoma skin cancers (squamous cell carcinoma and basal cell carcinoma), and actinic keratoses was compared between vitiligo cases and controls using Cox regression. A total of 15,156 vitiligo cases were matched to 60,615 controls. Vitiligo was associated with a 38% reduced risk of new-onset skin cancer (adjusted hazard ratio [aHR] = 0.62, 95% confidence interval [CI] = 0.52-0.75, P < 0.001) and skin cancer subtypes; melanoma (aHR = 0.39, 95% CI = 0.23-0.65, P < 0.001), squamous cell carcinoma (aHR = 0.67, 95% CI = 0.49-0.90, P < 0.01), basal cell carcinoma (aHR = 0.65, 95% CI = 0.51-0.83, P < 0.001). There was no significant association for actinic keratosis (aHR = 0.88, 95% CI = 0.77-1.01). People with vitiligo have a markedly reduced incidence of melanoma and nonmelanoma skin cancer. Given concerns that some treatments, such as phototherapy, may increase skin cancer risk, this finding provides reassurance to people with vitiligo and clinicians managing the condition.
引用
- Ferguson J, Eleftheriadou V, Nesnas J, et al. Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study. J Invest Dermatol. 2023. PMID: 37146674. doi:10.1016/j.jid.2023.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。